These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 15183059)

  • 21. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.
    Boutard B; Vankerckhove S; Markine-Goriaynoff N; Sarlet M; Desmecht D; McFadden G; Vanderplasschen A; Gillet L
    PLoS One; 2015; 10(2):e0118806. PubMed ID: 25705900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits.
    Mossman K; Lee SF; Barry M; Boshkov L; McFadden G
    J Virol; 1996 Jul; 70(7):4394-410. PubMed ID: 8676463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent Evolutionary Pathways of Myxoma Virus in Australia: Virulence Phenotypes in Susceptible and Partially Resistant Rabbits Indicate Possible Selection for Transmissibility.
    Kerr PJ; Cattadori IM; Sim D; Liu J; Holmes EC; Read AF
    J Virol; 2022 Oct; 96(20):e0088622. PubMed ID: 36197107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses to myxoma virus.
    Kerr P; McFadden G
    Viral Immunol; 2002; 15(2):229-46. PubMed ID: 12081009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis.
    Hnatiuk S; Barry M; Zeng W; Liu L; Lucas A; Percy D; McFadden G
    Virology; 1999 Oct; 263(2):290-306. PubMed ID: 10544103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myxomatosis. The effect of age upon survival of wild and domestic rabbits (Oryctolagus cuniculus) with a degree of genetic resistance and unselected domestic rabbits infected with myxoma virus.
    Sobey WR; Conolly D; Haycockp ; Edmonds JW
    J Hyg (Lond); 1970 Mar; 68(1):137-49. PubMed ID: 5267123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation.
    Zúñiga MC
    Virus Res; 2002 Sep; 88(1-2):17-33. PubMed ID: 12297325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions.
    Adams MM; van Leeuwen BH; Kerr PJ
    Vaccine; 2008 Oct; 26(46):5843-54. PubMed ID: 18789367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the virulence of five strains of amyxomatous myxoma virus in crossbred New Zealand White/Californian conventional rabbits, with evidence of long-term testicular infection in recovered animals.
    Marlier D; Mainil J; Sulon J; Beckers JF; Linden A; Vindevogel H
    J Comp Pathol; 2000; 122(2-3):101-13. PubMed ID: 10684679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.
    Messud-Petit F; Gelfi J; Delverdier M; Amardeilh MF; Py R; Sutter G; Bertagnoli S
    J Virol; 1998 Oct; 72(10):7830-9. PubMed ID: 9733819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis.
    Lalani AS; Masters J; Graham K; Liu L; Lucas A; McFadden G
    Virology; 1999 Apr; 256(2):233-45. PubMed ID: 10191189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective.
    Adams MM; van Leeuwen BH; Kerr PJ
    Vaccine; 2004 Nov; 23(2):198-204. PubMed ID: 15531037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
    Liu J; Wennier S; Reinhard M; Roy E; MacNeill A; McFadden G
    J Virol; 2009 Jun; 83(11):5933-8. PubMed ID: 19279088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myxomatosis in the sub-antarctic islands of Kerguelen, without vectors, thirty years after its introduction].
    Chapuis JL; Chantal J; Bijlenga G
    C R Acad Sci III; 1994 Feb; 317(2):174-82. PubMed ID: 7994607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying resistance to myxomatosis in wild rabbits produces novel evolutionary insights.
    Cooke BD; Taggart P; Patel K
    Epidemiol Infect; 2023 Oct; 151():e182. PubMed ID: 37823321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination strategies against myxomavirus infections: are we really doing the best?
    Marlier D
    Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model of myxomatosis based on hormonal control of rabbit-flea reproduction.
    Antonelli PL; Seymour RM
    IMA J Math Appl Med Biol; 1988; 5(1):65-80. PubMed ID: 3392434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate resistance to myxomatosis in wild rabbits in England.
    Ross J; Sanders MF
    J Hyg (Lond); 1977 Dec; 79(3):411-5. PubMed ID: 270526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of attenuated strain of myxoma virus].
    Maral R
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(8):737-9. PubMed ID: 4992294
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.
    Marlier D; Mainil J; Boucraut-Baralon C; Linden A; Vindevogel H
    J Comp Pathol; 2000; 122(2-3):115-22. PubMed ID: 10684680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.